临床儿科杂志 ›› 2018, Vol. 36 ›› Issue (1): 57-.doi: 10.3969/j.issn.1000-3606.2018.01.013

• 综合报道 • 上一篇    下一篇

甲硫氨酸腺苷转移酶活性缺陷致高甲硫氨酸血症 3 例报告

马艳艳 1, 李东晓 2, 李溪远 2, 宋金青 2, 刘玉鹏 2, 丁圆 2, 杨艳玲 2   

  1. 1.青海大学附属医院科研管理部、儿科(青海西宁 810001);2.北京大学第一医院儿科(北京 100034)
  • 收稿日期:2018-01-15 出版日期:2018-01-15 发布日期:2018-01-15
  • 通讯作者: 杨艳玲 E-mail:organic.acid@126.com
  • 基金资助:
    国家自然科学基金(No.81471097);国家自然科学青年基金(No.81400939);青海省应用基础研究(No.2016-ZJ-730)

Hypermethioninemia caused by deficient activity of methionine adenosyltransferase

 MA Yanyan1, LI Dongxiao2, LI Xiyuan2, SONG Jingqing2, LIU Yupeng2, DING Yuan2, YANG Yanling2   

  1. 1. Qinghai University Affiliated Hospital, Xining 810001, Qinghai; 2. The First Hospital of Peking University, Beijing 100034, China
  • Received:2018-01-15 Online:2018-01-15 Published:2018-01-15

摘要: 目的 探讨甲硫氨酸腺苷转移酶缺陷导致的高甲硫氨酸血症患儿的临床表现和分子遗传学特点。方法 回 顾分析3例因甲硫氨酸腺苷转移酶缺陷导致的高甲硫氨酸血症患儿的临床资料及相关基因分析,并进行核心家系分析。 结果 3例患儿,男孩2例,女孩1例,年龄5个月~ 3岁,来自3个不相关的家系;均无阳性家族史。 1例在新生儿筛查时被 发现, 1例于1个月时病理性黄疸发病,另1例于2岁时因手抖和生长发育落后而就诊。血氨基酸酯酰肉碱谱分析均显示甲 硫氨酸显著增高,134.50~790.67 μmol/L。患儿均为甲硫氨酸腺苷转移酶编码基因MAT1A突变; 1例为复合杂合突变, 第3外显子c.274T>C和第7外显子c.895C>T突变; 1例为第6外显子c.757G>A纯合突变;另1例为第7外显子c.791G>A 纯合突变。核心家系分析示患儿的突变均分别来自父母。结论 对于以神经系统损害为主要表现的患儿应考虑到甲硫氨 酸代谢障碍性疾病,血氨基酸和基因分析是明确诊断的重要方法。新生儿筛查是发现此病的有效方法。

Abstract: Objective To investigate the clinical and molecular genetic characteristics of hypermethioninemia caused by methionine adenosyltransferase deficiency. Methods The clinical data and related gene analysis of hypermethioninemia caused by methionine adenosyltransferase deficiency in 3 children were retrospectively analyzed. The core pedigree analysis was carried out. Results Three children (2 boys and 1 girl) aged from 5 months to 3 years, were from 3 unrelated families. All of them had no family history. One case was found in neonatal screening. One case was onset with pathological jaundice at 1 month old. Another case was found due to tremor and growth retardation at 2 years old. Blood amino acid ester acyl carnitine spectrum analysis showed that all of them had significantly elevated levels of methionine at 134.50-790.67 μmol/L. All children had MAT1A mutation in methionine adenosyltransferase gene. One case was heterozygous mutations with third exon c.274T>C and seventh exon c.895C>T mutation; one case had sixth exon c.757G>A homozygous mutation; and another case had seventh exon c.791G>A homozygous mutation. The core pedigree analysis showed that the mutations were from theirs parents respectively. Conclusions For children with neurologic impairment, methionine metabolic disorders should be considered. Blood amino acids and gene analysis are important methods for confirmation of the diagnosis. Neonatal screening is an effective way to detect this disease.